The National Pharmaceutical Pricing Authority (NPPA) on Monday said they have decided to meet again on February 8 to deliberate on the new stent prices.
"After day-long hearing of the views of all the stakeholders, Authority to meet again on February 08, as an extended meeting, to deliberate on new stent prices with the concerns of all on board," said the NPPA in a tweet.
Earlier, the NPPA had decided to meet on February 5 with the stakeholders to decide on revision of the stent pricing capping, which was done in 2017.
Concerned over the issue, Medical Technology Association of India (MTAI) has recommended to the NPPA to consider creating sub-categories for stents to ensure that significant technological innovation stays commercially rewardable.
"Continuing in the spirit of inclusiveness, we request the ministry of Health and Family Welfare to reconstitute the NLEM committee to enable inclusion of representatives from other relevant sections of the healthcare ecosystem. The broader constitution will give a real chance to the committee to review its previous decision on price capping," said MTAI in a statement.
It said that the committee, in its current form, is invested in the decision it took last year and the review would be fair if it is done by a broader panel.
--IANS
rup/qd/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
